• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结节病的医学治疗。

Medical therapy of sarcoidosis.

机构信息

Department of Medicine, University of Cincinnati Medical Center, Cincinnati, Ohio.

出版信息

Semin Respir Crit Care Med. 2014 Jun;35(3):391-406. doi: 10.1055/s-0034-1376401. Epub 2014 Jul 9.

DOI:10.1055/s-0034-1376401
PMID:25007090
Abstract

For treatment of sarcoidosis, one should develop a long-term management plan. Factors to be considered include the organ involvement and severity of symptoms. Different organ manifestations may require different treatments. Intensity of treatment is usually based on severity of disease or potential for organ failure or death. Glucocorticoids are quite effective as initial therapy for most forms of sarcoidosis. However, the toxicity associated with long-term treatment often leads to the use of alternative treatments. These include cytotoxic agents such as methotrexate, biologic agents such as the antitumor necrosis factor antibody infliximab, and other anti-inflammatory drugs such as hydroxychloroquine. In some cases, anti-inflammatory drugs may not help. Examples include pulmonary hypertension and fibrosis.

摘要

对于结节病的治疗,应制定长期管理计划。需要考虑的因素包括器官受累和症状严重程度。不同的器官表现可能需要不同的治疗方法。治疗强度通常基于疾病的严重程度或发生器官衰竭或死亡的风险。糖皮质激素是大多数类型结节病初始治疗的有效药物。然而,长期治疗相关的毒性常导致需要使用替代治疗。这些治疗包括细胞毒性药物如甲氨蝶呤、生物制剂如抗肿瘤坏死因子抗体英夫利昔单抗,以及其他抗炎药物如羟氯喹。在某些情况下,抗炎药物可能无效。例如肺动脉高压和纤维化。

相似文献

1
Medical therapy of sarcoidosis.结节病的医学治疗。
Semin Respir Crit Care Med. 2014 Jun;35(3):391-406. doi: 10.1055/s-0034-1376401. Epub 2014 Jul 9.
2
[Sarcoidosis treatment].[结节病的治疗]
Rev Prat. 2008 May 31;58(10):1099-104.
3
Current Medical Therapy for Sarcoidosis.结节病的当前医学治疗方法。
Semin Respir Crit Care Med. 2017 Aug;38(4):523-531. doi: 10.1055/s-0037-1604032. Epub 2017 Jul 27.
4
[Bilateral optic neuropathy revealing systemic sarcoidosis].[双侧视神经病变揭示系统性结节病]
Rev Med Interne. 2004 Oct;25(10):755-8. doi: 10.1016/j.revmed.2004.07.002.
5
[Sarcoidosis: changing insights in therapy].[结节病:治疗方面不断变化的见解]
Ned Tijdschr Geneeskd. 2010;154(47):A1685.
6
Established and experimental medical therapy of pulmonary sarcoidosis.肺结节病的既定和实验性医学治疗。
Eur Respir J. 2013 Jun;41(6):1424-38. doi: 10.1183/09031936.00060612. Epub 2013 Feb 8.
7
Treatment of sarcoidosis.结节病的治疗。
Panminerva Med. 2013 Jun;55(2):175-89.
8
Sarcoidosis: an update on current pharmacotherapy options and future directions.结节病:当前药物治疗选择及未来方向的最新进展
Expert Opin Pharmacother. 2016 Dec;17(18):2431-2448. doi: 10.1080/14656566.2016.1258061.
9
Long term follow-up of infliximab efficacy in pulmonary and extra-pulmonary sarcoidosis refractory to conventional therapy.英夫利昔单抗治疗常规治疗抵抗的肺及肺外结节病的长期随访。
Semin Arthritis Rheum. 2013 Aug;43(1):119-24. doi: 10.1016/j.semarthrit.2012.10.008. Epub 2013 Jan 16.
10
Hypercalcemia from sarcoidosis successfully treated with infliximab.英夫利昔单抗成功治疗结节病所致高钙血症。
Sarcoidosis Vasc Diffuse Lung Dis. 2012 Mar;29(1):51-2.

引用本文的文献

1
Risk of gastrointestinal events among patients with sarcoidosis: a population-based study 1976-2013.结节病患者胃肠道事件的风险:一项基于人群的1976 - 2013年研究
Sarcoidosis Vasc Diffuse Lung Dis. 2018;35(3):239-244. doi: 10.36141/svdld.v35i3.6561. Epub 2018 Apr 28.
2
Autoimmunity and autoinflammation: A systems view on signaling pathway dysregulation profiles.自身免疫与自身炎症:信号通路失调特征的系统观。
PLoS One. 2017 Nov 3;12(11):e0187572. doi: 10.1371/journal.pone.0187572. eCollection 2017.
3
New molecular targets for the treatment of sarcoidosis.
结节病治疗的新分子靶点。
Curr Opin Pulm Med. 2016 Sep;22(5):515-21. doi: 10.1097/MCP.0000000000000304.
4
ProKaSaRe Study Protocol: A Prospective Multicenter Study of Pulmonary Rehabilitation of Patients With Sarcoidosis.普罗卡萨雷研究方案:结节病患者肺康复的前瞻性多中心研究。
JMIR Res Protoc. 2015 Dec 4;4(4):e134. doi: 10.2196/resprot.4948.
5
Impaired survival of regulatory T cells in pulmonary sarcoidosis.结节病中调节性T细胞存活受损。
Respir Res. 2015 Sep 16;16(1):108. doi: 10.1186/s12931-015-0265-8.
6
Cough in Sarcoidosis.结节病中的咳嗽。
Lung. 2016 Feb;194(1):21-4. doi: 10.1007/s00408-015-9799-2. Epub 2015 Sep 9.